VERA
#1860
Vera Therapeutics, Inc. - Class A Common Stock
34.0 8 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.32%
Monthly Change
+7.10%
6 month change
-14.67%
Year Change
+14.59%
Previous Close
34.1 9
Open
34.0 8
Low
34.0 8
High
34.0 8
Volume
89
Financials
- Market Capitalization 2.46 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.32
Price to sales ratio
-2 874.39
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1856 |  PGEN Precigen, Inc. - Common Stock | 6.93 USD | -0.29% | -4.94% | +11.24% | +54.34% | 2.48 B USD | ||
| 1857 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.70 USD | -1.22% | -0.92% | +7.78% | +15.89% | 2.48 B USD | ||
| 1868 |  NKTR Nektar Therapeutics - Common Stock | 71.38 USD | -1.57% | -4.80% | +0.93% | -2.58% | 2.44 B USD | ||
| 1887 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 16.60 USD | -1.13% | -9.24% | -9.44% | +132.17% | 2.37 B USD |
Frequently asked questions about Vera Therapeutics, Inc. Class A Common Stock
What is the Vera Therapeutics, Inc. Class A Common Stock stock price today?
The current price of Vera Therapeutics, Inc. Class A Common Stock (VERA) is 34.08. Over the past 24 hours, the stock has changed by -0.32%. Follow the VERA chart for real-time price dynamics.
What is the stock ticker of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock trades under the ticker VERA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vera Therapeutics, Inc. Class A Common Stock stock going up?
VERA has changed by +0.09% over the last week, +7.10% over the last month, and +14.59% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vera Therapeutics, Inc. Class A Common Stock?
Vera Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 2.46 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vera Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, Vera Therapeutics, Inc. Class A Common Stock reported earnings of -1.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vera Therapeutics, Inc. Class A Common Stock revenue for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported quarterly revenue of -483 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vera Therapeutics, Inc. Class A Common Stock net income for the last quarter?
Vera Therapeutics, Inc. Class A Common Stock reported net income of -109.47 M for the last quarter. The previous quarter showed -121.03 M, which means net income changed by +9.55%.
How many employees does Vera Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, Vera Therapeutics, Inc. Class A Common Stock has 361 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vera Therapeutics, Inc. Class A Common Stock EBITDA?
Vera Therapeutics, Inc. Class A Common Stock EBITDA is -112.84 M, and its EBITDA margin is 23.36 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vera Therapeutics, Inc. Class A Common Stock stock?
You can buy Vera Therapeutics, Inc. Class A Common Stock (VERA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vera Therapeutics, Inc. Class A Common Stock stock?
Investing in Vera Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VERA chart and related analysis on metatrader.com as part of your research.